Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/0022-2011(69)90226-2 | DOI Listing |
J Emerg Manag
August 2024
University of Religions and Denominations, Qom, Iran; Lecturer, Department of Political Science and International Relations, Anchor University, Lagos, Nigeria. ORCID: https://orcid.org/0000-0003-1135-6347.
The rapid breakout and dissemination of the coronavirus disease 2019 (COVID-19) infection from the city of Wuhan, China, to the rest of the countries of the world in December 2019 triggered a situation that led the World Health Organization to report it as a global public health emergency. The pandemic resulted in abrupt and significant loss of lives, disruption of economies, loss of livelihoods, and severe hardship across the nations of the world. Nigeria encountered the COVID-19 reality following the discovery of the first case of the infection in the country on February 27, 2020, prompting the government to swing into action to contain its spread.
View Article and Find Full Text PDFAim: To evaluate the efficacy and safety of riamilovir in the treatment of COVID-19 in adults.
Materials And Methods: The study included 180 patients with a laboratory-confirmed diagnosis of COVID-19 which fully meet the criteria for inclusion, non-inclusion and exclusion, signed a voluntary informed consent to participate in a clinical trial.
Results: The efficacy, good tolerability and safety of the drug riamilovir in the treatment of COVID-19 have been established.
J Epidemiol Glob Health
September 2024
Medical Unit of the Administrative Detention Centre (UMCRA), CHU Nîmes, Univ Montpellier, UMCRA 162 avenue Clément Ader, 30000, Nîmes, France.
Aim: Evaluation of the efficacy and safety of riamilovir as a drug for the prevention of coronavirus infection (COVID-19) in adults who have constant contact with COVID-19 patients as a result of living together.
Materials And Methods: The study included 750 adult participants living with patients with confirmed polymerase chain reaction method COVID-19, who had a negative polymerase chain reaction result for the SARS-CoV-2 virus at the initial level, met the criteria for inclusion, non-inclusion and exclusion, and signed a voluntary informed consent to participate in a clinical trial.
Results: The efficacy, good tolerability and safety of the drug riamilovir for the prevention of COVID-19 infection among people who have come into contact with COVID-19 patients in a family focus of infection have been established.
Sao Paulo Med J
August 2023
MD, MSc, PhD. Adjunct Professor, Department of Gynecology, Universidade Federal de São Paulo (UNIFESP), São Paulo (SP), Brazil.
Background: Given the characteristics of military missions, intense interpersonal contact, and wide variation in casual relationships, the military has long been recognized as a high-risk population for sexually transmitted infections (STIs).
Objective: To assess the prevalence of STIs and socioepidemiological profile of women in the military garrison of Campinas.
Design And Setting: This prospective, cross-sectional epidemiological study, assisted by the Health Fund in the military garrison of Campinas, assessed the prevalence of human immunodeficiency virus (HIV), hepatitis B and C, syphilis, human papillomavirus (HPV), chlamydia, and gonococcus in military women or companions of soldiers with active or previously active sexual life.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!